Your browser doesn't support javascript.
loading
Differential prognostic effect of revascularization according to a simple comorbidity index in high-risk non-ST-segment elevation acute coronary syndrome.
Palau, Patricia; Núñez, Julio; Sanchis, Juan; Husser, Oliver; Bodí, Vicente; Núñez, Eduardo; Miñana, Gema; Boesen, Line; Ventura, Silvia; Llàcer, Angel.
Afiliação
  • Palau P; Cardiology Department, Hospital Clinico Universitario, INCLIVA, Universidad de Valencia, Valencia, Spain. patri.palau@gmail.com
Clin Cardiol ; 35(4): 237-43, 2012 Apr.
Article em En | MEDLINE | ID: mdl-22083556
ABSTRACT

BACKGROUND:

Data on the effect of revascularization on outcome in patients with high-risk non-ST-segment elevation acute coronary syndrome (NSTEACS) and significant comorbidities are scarce. Recently, a simple comorbidity index (SCI) including 5 comorbidities (renal failure, dementia, peripheral artery disease, heart failure, and prior myocardial infarction [MI]) has shown to be a useful tool for risk stratification. Nevertheless, therapeutic implications have not been derived.

HYPOTHESIS:

We sought to evaluate the prognostic effect attributable to revascularization in NSTEACS according the SCI score.

METHODS:

We included 1017 consecutive patients with NSTEACS. The effect of revascularization on a combined end point of all-cause mortality or nonfatal MI was evaluated by Cox regression according to SCI categories.

RESULTS:

A total of 560 (55.1%), 236 (23.2%), and 221 (21.7%) patients showed 0, 1, and ≥2 points according to the SCI, respectively. Coronary angiography was performed in 725 patients (71.5%), and 450 patients (44.3%) underwent revascularization. During a median follow-up of 16 months (interquartile range, 12-36 months), 305 (30%) patients experienced the combined end point (202 deaths [19.9%] and 170 MIs [16.7%]). In multivariate analysis, a differential prognostic effect of revascularization was observed comparing SCI ≥2 vs 0 (P for interaction = 0.008). Thus, revascularization was associated with a greater prognostic benefit in patients with SCI ≥2 (hazard ratio [HR] 0.51, 95% confidence interval [CI] 0.29-0.89), P = 0.018), whereas no significant benefit was observed in those with 0 and 1 point (HR 1.31, 95% CI 0.88-1.94, P = 0.171 and HR 1.11, 95% CI 0.70-1.76, P = 0.651, respectively).

CONCLUSIONS:

In NSTEACS, the SCI score appears to be a useful tool for identifying a subset of patients with a significant long-term death/MI risk reduction attributable to revascularization.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Coronariana Aguda Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Cardiol Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Coronariana Aguda Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Cardiol Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Espanha